The global carboxy therapy market size was estimated at USD 33.88 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.9% from 2023 to 2030. The growth of the market for carboxy therapy is attributed to the rising adoption of non-invasive aesthetic procedures, technological advancement associated with aesthetic treatments, and the benefits and effectiveness associated with carboxy therapy. Moreover, rising awareness and availability of portable devices are further fueling market growth. The global population's desire to remain youthful and have a better appearance has grown as this leads to improved mental health and self-esteem. However, the COVID-19 pandemic has resulted in a halt of various cosmetic treatments as there were restrictions on healthcare services as a result of which the market has witnessed a downfall in terms of revenue generation. Moreover, the decline of these procedures was majorly to prioritize the resources and expenses towards necessary care. However, the later pandemic stage witnessed a surge in demand for aesthetic procedures, including carboxy therapy.
Carboxy therapy is seen as 100% natural and the use of carbon dioxide treatment helps in complimenting and enhancing various other cosmetic procedures and does not interfere with other procedures such as fillers, lasers, and botulinum toxins. Moreover, the devices are generally easy to use and come as portable and stationary units that enhance the adoption of carboxy therapy among the end-users. The increasing number of applications associated with these devices are further anticipated to boost the overall growth of the market.
Furthermore, the market is driven mainly by increasing aesthetic plastic surgery globally. According to recent statistics published by the International Society of Aesthetic Plastic Surgery (ISAPS), aesthetic and cosmetic procedures have seen a surge with an overall increase of 19.3% of plastic surgeries performed in 2021. Globally, there were an estimated 2.8 million surgical and 17.5 million non-surgical procedures performed with the highest number of procedures performed in the U.S. accounting for 24.1% of the total surgical and non-surgical procedures performed.
Moreover, recent technological advancements such as portable carboxy therapy devices, advances in safety features, automated carboxy therapy machines, etc. in the carboxy therapy market have focused on improving the delivery of carbon dioxide gas to the treatment area. This leads to reduced treatment time and increased treatment effectiveness. These advanced devices are designed to automatically inject carbon dioxide into the treatment area, further reducing the need for manual injections by the therapist and can make the treatment more efficient and consistent. They can also be used in remote locations or in a client's home and they can enhance the overall effectiveness of the treatment and provide more comprehensive results.
Based on product type, the tabletop carboxy therapy devices segment held the largest market share of 55.6% in 2022. The dominance of the segment is attributed to the increasing demand for aesthetic procedures in wellness and aesthetic clinics. With advancements in cosmetic surgeries novel procedures and devices are highly adopted and installed in healthcare systems to provide patients with a wide range of procedures. Moreover, the demand for tabletop carboxytherapy machine is rising owing to the use of the systems in pain management and medical aesthetics. However, the high cost associated with the system may result in restraining the growth of the segment.
However, the portable segment is expected to expand at the fastest growth rate over the forecast period. The growth of the segment can be attributed to the increasing patient spending on cosmetic procedures and beautification. The portable devices present in the market, including, Medical CO2 Carboxy Therapy Machine, Carboxy-Pen (a compact and mobile carboxy therapy device), and Concerto (a dual device with carboxytherapy and mesotherapy option) are all easy to use and are easily available in the market. They are highly adopted to be used for restoring, rejuvenating the skin, and treating stretch marks, laxity, cellulite, and wrinkles.
Based on end-use, aesthetic clinics held the dominant market share of 45.9% in 2022. The growth of the segment can be attributed to the lower cost of treatment at these clinics and the availability of cosmetic surgical procedures under the supervision of a licensed physician. Carboxy therapy procedures are offered in aesthetic clinics and required approximately around 15-30 minutes and require maintenance therapy after about every three to six months which increases the patients’ visits to aesthetic clinics further propelling the growth of the segment. In addition, the aesthetics clinics generally offer advanced cosmetic procedures that make it a prime location for carboxy therapy.
However, the medspa segment is expected to witness the fastest growth rate over the forecast period. Medical spa serves as a healthcare setting with an aim to provide rejuvenation and an advanced form of patient service keeping in mind providing the best patient experience. Carboxy therapy is a newer technology in the cosmetic industry and is highly adopted in medspa to provide advanced aesthetic treatments to patients. However, the cost of the procedure in medspa is high and is generally not covered by insurance or not reimbursed which is expected to restrain the growth of these procedures in medspa.
North America dominated the market with a share of 42.9% in 2022 and is anticipated to maintain its dominance over the forecast period. The high share of the market in the region can be due to the growth of the market in the U.S. In the U.S., a growing number of the population are focusing on the adoption of aesthetic procedures to maintain their rejuvenated skin. The region shows a high disposable income and high patient spending on cosmetic procedures that increases the adoption of the procedure. Moreover, the U.S. population is rapidly aging and is expected to grow significantly in the coming years. With the aging population comes various skin-related issues, including wrinkles, fine lines, and dehydration of the skin. Hence, these consumer demographics are key consumers for the market.
The Asia Pacific region is estimated to be the fastest-growing region during the forecast period. The market growth in the region can be attributed to the growing awareness regarding carboxy therapy and the benefits associated with it. Moreover, the aesthetic clinics offering such procedures are growing in the region and are offering advanced services in state-of-the-art facilities. However, the low income and lower cosmetic spending aided with a higher cost of such procedures in the region is expected to limit the growth of the market.
The market is highly fragmented, with the majority of the market share held by many small companies. The companies are focusing on adopting several strategies including product launches, strategic collaborations, and acquisitions to strengthen their market presence and further contribute to market growth. For instance, the Trolley Mounted Carboxy Treatment System is one of the most recent advancements in carboxy therapy units which was developed by UNITRONIC. Some of the key players in the global carboxy therapy market include:
DTA Medical
Cosmopro
Carbossiterapia Italiana
Mezopharma
MBE Medical Divisons
Beijing Jontelaser Technologies Co., Ltd.
Alvi Prague
Kastner-Praxisbedarf
MEDAiON Plasma
Report Attribute |
Details |
Market size value in 2023 |
USD 37.71 million |
Revenue forecast in 2030 |
USD 83.05 million |
Growth rate |
CAGR of 11.9% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product type, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
DTA Medical; Cosmopro; Carbossiterapia Italiana; Mezopharma; MBE Medical DivisonsDivisions; Beijing Jontelaser Technologies Co., Ltd.; Alvi Prague; Kastner-Praxisbedarf; MEDAiON Plasma |
Customization scope |
Free report customization (equivalent up to 8 analyst's working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global carboxy therapy market based on product type, end use, and regions:
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Table Top
Portable
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Aesthetic Clinics
Medspa
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global carboxy therapy market size was estimated at USD 33.88 million in 2022 and is expected to reach USD 37.71 million in 2023
b. The global carboxy therapy market is expected to grow at a compound annual growth rate of 11.9% from 2023 to 2030 to reach USD 83.05 million by 2030.
b. North America dominated in 2022 with the largest share, owing to the rising geriatric population and growing preference for aesthetic surgeries and procedures.
b. Some prominent players in the carboxy therapy market are: DTA Medical, Cosmopro, Carbossiterapia Italiana, Mezopharma, MBE Medical Divisons, Beijing Jontelaser Technologies Co., Ltd., Alvi Prague, kastner, and others
b. Growing demand for non-surgical and minimally invasive cosmetic procedures, especially among the aging population, and increasing awareness of the advantages that can be offered through carboxy therapy for improving skin texture is the major driver of the carboxy therapy market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."